| Heart Failure (HF) |
1 |
1 |
| Cardiac Resynchronization Therapy |
0 |
1 |
| Heart |
0 |
0.49 |
| Arrhythmia |
0 |
0.38 |
| Coronary Artery Disease (CAD) |
0 |
0.37 |
| Cardiomyopathy |
0 |
0.34 |
| Cardiovascular Imaging |
0 |
0.34 |
| Clinical Guidelines |
0 |
0.12 |
| Left Bundle Branch Block |
0 |
0.1 |
| Ejection Fraction |
0 |
0.08 |
| Electrophysiology |
0 |
0.04 |
| Implantable Cardioverter-Defibrillator |
0 |
0.04 |
| ACE Inhibitor |
0 |
0.02 |
| Artery |
0 |
0.02 |
| Canada |
0 |
0.02 |
| Defibrillator |
0 |
0.02 |
| Match |
0 |
0.02 |
| Muscle |
0 |
0.02 |
| New York |
0 |
0.02 |
| Otolaryngology |
0 |
0.02 |
| Right Bundle Branch Block |
0 |
0.02 |
| SGLT2 Inhibitor |
0 |
0.02 |
| Sinus |
0 |
0.02 |
| Type 2 Diabetes Mellitus |
0 |
0.02 |
| Weakness |
0 |
0.02 |